On May 12, 2025, President Donald Trump issued an Executive Order (EO) entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” with the goal of ensuring Americans pay no more for prescription drugs than other developed nations.
The EO directed the Secretary of Health and Human Services to communicate most-favored-nation (MFN) price targets to manufacturers








